A review was performed to determine the evidence base for scrub typhus indirect immunofluorescence assay (IFA) methodologies and the criteria for positive results. This review included a total of 109 publications, which comprised 123 eligible studies for analysis (14 publications included 2 substudies). There was considerable underreporting of the IFA methodology and seropositivity criteria used, with most studies using a defined cutoff titer rather than an increase in the titer in paired samples. The choice of positivity cutoff titer varied by country and purpose of the IFA test. This variation limits the comparability of seroprevalence rates between studies and, more seriously, raises questions about the appropriateness of the cutoffs for positive IFA results chosen for diagnosis of acute scrub typhus infection. We suggest that the diagnosis of scrub typhus using IFA should be based on a у4-fold increase in the titer in paired serum samples and should only be based on a single sample titer when there is an adequate local evidence base.
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Scrub typhus infection is caused by the intracellular bacterium Orientia tsutsugamushi [1] . This miteborne infection is endemic across much of Asia and the Western Pacific region, and it causes substantial morbidity in an area stretching from Pakistan [2] and India [3, 4] to Indonesia [5] and Australia [6, 7] and to Japan [8] and Korea [9, 10] . According to the World Health Organization, "Scrub typhus is probably one of the most underdiagnosed and under-reported febrile illnesses requiring hospitalisation in the region" [11, p. 123] . There is substantial variation in reported seroprevalence and mortality rates that may arise from dif-ferences in the methodologies used to diagnose scrub typhus infection and to detect past exposure to the organism, differences in patient characteristics, differences in endemicity rates, and geographical differences. The hypothesized variation in pathogenicity between O. tsutsugamushi strains may also play a role [12, 13] .
The mainstay of scrub typhus diagnosis and of epidemiology studies is serologic testing. The gold standard assay for the serologic detection of scrub typhus antibodies is the indirect immunofluorescence assay (IFA) [14, 15] ; however, other tests, such as the indirect immunoperoxidase and Weil-Felix assays, are also used. The IFA was first described in 1963 by Bozeman et al. [12] and has subsequently been modified to allow the use of smaller volumes of serum and antigens [16, 17] . The IFA uses epifluorescence to visualize a fluoresceinlinked anti-human antibody conjugate to detect the presence of scrub typhus-specific antibody bound to smears of scrub typhus antigen [12] . However, there is little consensus apparent in the choice of IFA meth-odology (i.e., antigenic strains and antibody isotype) and of the positivity cutoff limits for diagnostic and epidemiologic purposes. From a diagnostic standpoint, this lack of consensus raises a number of questions: (1) What is the most appropriate IFA methodology in a given setting? (2) What is the most appropriate positive cutoff titer to make an accurate diagnosis? (3) And how does one determine appropriate positivity cutoff limits for seroepidemiology studies in a setting of endemicity? Here, we present the findings of an extensive review of scrub typhus IFA methodologies and diagnostic criteria used in previously published diagnostic and seroprevalence studies, describing the nature of methodological variations and determining the strength of evidence for the application of seropositivity cutoff values.
MATERIALS AND METHODS
Article selection. A search of the PubMed electronic database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) was performed for the period from 1963 to June 2005 using the following criteria, with no language restrictions imposed: ((scrub typhus) OR (tsutsugamushi)) AND ((diagnosis) OR (diagnostic)) OR ((immunofluorescen*) OR (fluoresce*) OR (IFA)).
Articles with abstracts available online were examined for relevance to this study, and full-text articles were obtained for all selected studies. Additional studies were located by in-study citation or by hand search of reference lists. For a study to be included in the systematic review, it had to meet the following criteria: (1) IFA was used to detect antibodies to O. tsutsugamushi, (2) the tests were applied to human subjects (i.e., not animal studies), and (3) the study was published in a peerreviewed journal.
Data extraction form. A data extraction form was created and tested for suitability on 5 randomly selected articles. The data extraction form included fields under the following headings: citation information, demography, scrub typhus prevalence, study design, IFA characteristics, and notes. The following definitions were used to standardize data extraction.
1. Prevalence was calculated by dividing the number of scrub typhus antibody-positive patients (i.e., from seroepidemiology studies) or patients with confirmed cases (i.e., from diagnostic studies) using IFA by the total number of patients tested. Prevalence was calculated separately for hospital-based fever studies and seroprevalence studies, and it was not calculated for case reports or case-control studies. To calculate geographically relevant prevalence rates, patient results (i.e., scrub typhus antibody-positive or -negative results) were analyzed on the basis of the country of exposure rather than the country where IFA was performed.
2. Studies that used IFA were classified as follows.
A. Diagnostic studies. Case reports were defined as clinical descriptions of у1 scrub typhus case for which IFA was used for diagnosis. In cause-of-fever studies, IFA was used for the diagnosis of scrub typhus.
B. Seroepidemiologic studies. In these studies, IFA was used to determine scrub typhus positivity and was not used to diagnose illness in patients.
C. Assay development/diagnostic accuracy studies. In these studies, IFA was used as a gold standard or reference comparator when assessing the sensitivity or specificity of other means of diagnosis (e.g., a new diagnostic technique) or was being examined itself to determine its sensitivity and specificity.
Data extraction. Each article was allocated a unique study number, and study information was extracted onto the data extraction form by one investigator (N.J.B.); the result was validated by an independent reviewer (S.D.B.). Disagreement was resolved through mediation with a third independent reviewer (D.H.P.). English-and French-language articles were extracted directly, whereas Chinese-and Japanese-language articles were extracted in the presence of a translator.
Quality assessment. Criteria for quality assessment scores were developed on the basis of 5 key criteria contained in the Standards for Reporting of Diagnostic Accuracy checklist [18] , as follows: (1) Was the IFA methodology referenced? (2) Were the antigens used described? (3) Was the antibody isotype(s) (IgM or IgG or both) stated? (4) Was at least 1 criterion for positive results described? and (5) Were the criteria for positive IFA results justified? Studies were scored 0 or 1 for each quality criterion, and scores from a possible value of 5 were calculated. Studies that detailed IFA as a novel method, that determined criteria for seropositivity by IFA, or that used the IFA experimentally were excluded from quality assessment.
Data analysis. Data analysis was performed using Stata software, version 8.0 (StataCorp). Multiple linear regression and analysis of variance were performed to investigate relationships between the prevalence of O. tsutsugamushi infection, the antibody cutoff titer used, the years that the studies were published, and the study population. The Kruskal-Wallis test was used to test for independence of the cutoff titer and the purpose of the IFA. Trend analysis of study quality scores used the nptrend test [19] .
RESULTS
Article selection. A total of 510 published studies were located in the original search, and 109 were included in the final review. Because 14 publications each described 2 substudies, the total number of studies analyzed was 123. The study selection and rejection process is detailed in figure 1 .
General characteristics of the studies. Of the selected 109 publications, 92 (84%) were in English, 14 (13%) were in Japanese, 2 (2%) were in Chinese, and 1 (1%) was in French. The publication dates of the studies ranged from 1963, when the use of IFA for diagnosis of scrub typhus was first described, to April 2005. Of the 123 studies, IFA was used in 65 diagnosis studies (53%; i.e., case reports plus cause-of-fever studies), 28 seropositivity studies (23%), and 30 assay development/diagnostic accuracy studies (24%). The studies were performed in 12 countries, and in most studies (105 [85%] of 123), the country where the IFA was performed was also the one in which the population was exposed to O. tsutsugamushi. Exceptions were those studies investigating scrub typhus in travelers [20] [21] [22] [23] [24] , those in which samples were sent elsewhere for testing [25] [26] [27] [28] [29] [30] [31] , or those in which samples from populations from 11 country were tested [22, 32] . In 6 publications (involving 7 studies), the country in which the IFA was performed was not stated [12, 21, [33] [34] [35] , although the country of exposure was described (tables 1 and 2). The majority of studies were performed in Japan (31 of 24 studies) was 1:400. Nine diagnostic studies (14%) exclusively used a у4-fold increase in antibodies in paired serum samples, whereas 10 studies (15%) used this criterion in conjunction with a fixed titer cutoff. The majority of seroepidemiology studies (21 [81%] of 28) used a single cutoff titer to determine positive results, with a wide range of reported cutoff values (1:10-1:400); 1:50 was the most widely used value (7 [25%] ). Fourteen (47%) of 30 assay development/diagnostic accuracy studies used positivity cutoff titers ranging from 1:20 to 1:400. The cutoff titers used were not significantly different between the studies when grouped by purpose ( ). P p . 22 The cutoff values for positive results that were used varied significantly among geographical areas ( ) (table 2) . P p .012 Among diagnostic studies, there was a notable geographical difference between the cutoffs used in Thailand and Malaysia (range, 1:50-1:400) and those used in Japan and Korea (range, 1:10 to 1:40).
Justification for seropositivity criteria. Of the 69 studies that stated a criterion used for seropositive results (cutoff and/ or у4-fold increase in the titer), only 25 (41%) justified use by citing a supporting previous study. The most frequently cited seropositivity criteria study was that of Brown et al. [36] (in 12 [48%] of 25 studies), which suggested a cutoff titer of 1: 400 and a у4-fold increase in the titer in paired serum samples and which was the only study that validated seropositivity limits. An additional 5 references [17, [37] [38] [39] [40] were cited for justification by 7 studies. The 2 remaining articles cited were not included in this review, because they did not meet the inclusion criteria (they were both book chapters).
Comparison of target antibody isotype. Sixty-seven (54%) of 123 studies stated the targeted antibody isotype. Testing for both IgG and IgM antibodies against O. tsutsugamushi was the 
Total no. (%) of studies 6 (4.9) 3 (2.4) 11 (9.0) 11 (9.0) 4 (3. used was often country specific, because local antigens were often added to the standard Kato, Karp, and Gilliam antigen pools. Quality assessment. One hundred fifteen studies were eligible for quality scoring; the other 8 studies were excluded because their aim was to define IFA as a new method. Cause of fever (median quality assessment score, 3; interquartile range [IQR], 2-4), seroepidemiology (median quality assessment score, 3; IQR, 3-4), and assay development/diagnostic accuracy (median quality assessment score, 3; IQR, 2-4) study types all earned the highest quality scores, with case studies having the lowest (median quality assessment score, 2; IQR, 1-3). Although there was a discernable improvement in quality scores from the earliest to later studies, analysis of the moving average (by year) of quality scores did not demonstrate a significant trend ( ) of increasing quality over time (figure 2). Stud-P p .81 ies that reported a positivity criterion also cited an IFA methodology in 75% of cases (45 of 60), whereas 63% (40 of 63) of studies that did not report a positivity criterion did not cite an IFA methodology.
Prevalence rates. Prevalence data were extractable from 32 individual studies (table 4) . There was a significant overall correlation between prevalence rates and positivity cutoff titers ( ; ), which was even higher in studies spe- 
DISCUSSION
This review highlights the variation both in scrub typhus IFA methodologies (i.e., antigens, antibody isotypes, and methods) and in the seropositivity criteria used for interpretation of results. In many cases, a clear justification for the methodology and cutoff used was not provided, and it is likely that differences in approach evolved naturally on the basis of local antigenic strains and the pretest odds of disease, depending on the local level of scrub typhus endemicity. This variation makes it dif- ficult to compare seroprevalence rates between studies and, more seriously, raises questions about which (if any) IFA positivity cutoff value is the most appropriate for the diagnosis of acute scrub typhus infection. In recent years, the quality of study methodology descriptions has improved steadily, although many recent papers still lack important information. The checklist created by the Standards for Reporting of Diagnostic Accuracy working group [18] is a useful guide to the information that should be provided when reporting diagnostic accuracy studies, and most of their criteria are also relevant to the reporting of seroepidemiology studies. Studies involving the use of IFA should, at a minimum, report the cutoff titer (with justification), the antigens and antibody isotypes used, and the number of people interpreting the IFA results. It is interesting to note that 2 studies (included in this review) [41, 42] that validated seropositivity cutoff titers for scrub typhus IFA were not cited by any of the other studies included in this review.
This review describes the wide variation in the choice of scrub typhus seropositivity cutoff titers, and the significant relationship demonstrated between the cutoff titer used and prevalence rate highlights the practical importance of this variability. It has been recommended previously that the "IFA should be considered a technique for seroepidemiology only in areas where the seroprevalence of rickettsial disease has already been established" [14, p. 2723] . We suggest that clinicians in countries where scrub typhus is endemic should perform preliminary studies in different geographical locations to determine the level of normal scrub typhus immunity (IgM and IgG) in otherwise healthy populations (e.g., donors of blood bank samples), so that an evidence-based positivity cutoff titer can be derived for the diagnosis of acute illness. We also suggest that seroprevalence rates be interpreted with caution and that the use of high cutoff titers to determine seroprevalence rates may mask high rates of background immunity.
Early diagnosis of scrub typhus leads to early appropriate antibiotic treatment, which can greatly reduce the chance of life-threatening complications [43] [44] [45] [46] . To what extent should geographical variations in disease incidence and serological prevalence guide decisions on which serological method and positivity cutoff to use? Scrub typhus is an important travelrelated illness [15] , and if it is suspected in (for example) an American traveler returning from a short trip to Japan and Thailand, should the cut off level used to interpret the IFA result be that used in Japan or Thailand or that used in America? What defines seropositivity in such a case? This example highlights the confusion surrounding scrub typhus serologic studies and the need for consensus. From the data presented here, no single antibody titer can reliably be considered diagnostic unless prior studies have been performed to determine the seroprevalence levels in the normal population of a locality [14, 40] . In practice, diagnosis is often made using a single serum sample because of the difficulties in obtaining paired serum samples [25, [47] [48] [49] . To differentiate between background scrub typhus immunity in a region of endemicity and acute disease, it is essential to obtain 2 sequential samples to assess the dynamics of the antibody response. We agree with a previous recommendation [14] that, for patients from an area where scrub typhus is endemic, an accurate diagnosis of scrub typhus using IFA can only be conclusively made on the basis of a у4-fold increase in the titer in paired serum specimens, and results obtained from single acute-phase samples based on locally validated positivity titer criteria [36, 41] from an adequate evidence base may also be clinically informative. Travellers who are from areas where scrub typhus is not endemic and who have recently returned from areas where it is endemic may be preliminarily diagnosed on the basis of the detection of a single positive titer, because many acutely infected patients have high scrub typhus IgM and IgG antibody titers and are unlikely to have been previously exposed [20, [22] [23] [24] . However, examination of paired specimens collected at least 14 days apart is the only method to provide a definitive serologic diagnosis [15] .
Many of the inconsistencies highlighted in this review were recognized in 1986 by a World Health Organization task force examining issues relating to scrub typhus serology [50] . They suggested the standardization of antigens, antibody isotypes, an open exchange of O. tsutsugamushi isolates, and "the promotion of ideas to standardize serological tests for the diagnosis of tsutsugamushi disease should be expedited by the exchange and multi-laboratory evaluation of new isolates, isolate specific sera and various new diagnostic methodologies" [124, p. 156] . It is clear 20 years later that the same issues remain, and the need to resolve them remains urgent. Even if a consensus on IFA methodology can be made, differences in endemicity and pathogenicity of strains will always lead to discrepancies. For this reason, studies to determine the level of background immunity and the true incidence of disease in a given area will greatly assist diagnostic interpretation. More emphasis should also be placed on the development of rapid and inexpensive non-serology-based means of diagnosis, such as nucleic acid amplification or antigen detection.
